Neonatal cholestasisGene: UTP4
Comment when marking as ready: Based on literature review
Created: 21 Aug 2018, 8:44 a.m.
OMIM reports that a R565W homozygous substitution was found in all patients from 5 families with North American Indian childhood cirrhosis (NAIC; 604901), Chagnon et al. (2002)(PMID: 12417987). Function evidence from Freed et al. (2012) (PMID:22916032) reported that this variant reduces interaction between cirhin and NOL11. However, Lek et al. (2016)(PMID:22916032) found that the ExAC database contained 222 heterozygous and 4 homozygous Latino individuals carrying the CIRH1A (UPT4) R565W mutation, for a population frequency of 1.92%. The 4 homozygous individuals had no history of liver disease; recontact with 2 of them revealed normal liver function at ages 56 and 53. Lek et al. (2016) classified this variant as benign. Gene2Phenotype lists the association of CIRH1A and NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS as possible. A literature search didn't find any other publications supporting an association of this gene with cholestasis or other neonatal liver disease.
Created: 15 Aug 2018, 1:24 p.m.
This panel has been subjected to extensive internal and external review.
Gene: utp4 has been classified as Red List (Low Evidence).
UTP4 was added to Cholestasis panel. Sources: UKGTN
UTP4 was created by Ellen McDonagh